EP0711310A4 - Human antibodies against varicella-zoster virus - Google Patents
Human antibodies against varicella-zoster virusInfo
- Publication number
- EP0711310A4 EP0711310A4 EP94922669A EP94922669A EP0711310A4 EP 0711310 A4 EP0711310 A4 EP 0711310A4 EP 94922669 A EP94922669 A EP 94922669A EP 94922669 A EP94922669 A EP 94922669A EP 0711310 A4 EP0711310 A4 EP 0711310A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- human antibodies
- antibodies against
- zoster virus
- against varicella
- varicella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000701085 Human alphaherpesvirus 3 Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/088—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9847993A | 1993-07-28 | 1993-07-28 | |
US08/217,918 US5506132A (en) | 1993-07-28 | 1994-03-24 | Human antibodies against varicella-zoster virus |
PCT/US1994/008241 WO1995004080A1 (en) | 1993-07-28 | 1994-07-22 | Human antibodies against varicella-zoster virus |
US98479 | 1998-06-16 | ||
US217918 | 1998-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0711310A1 EP0711310A1 (en) | 1996-05-15 |
EP0711310A4 true EP0711310A4 (en) | 1998-08-05 |
Family
ID=26794782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94922669A Withdrawn EP0711310A4 (en) | 1993-07-28 | 1994-07-22 | Human antibodies against varicella-zoster virus |
Country Status (6)
Country | Link |
---|---|
US (1) | US5506132A (en) |
EP (1) | EP0711310A4 (en) |
JP (1) | JPH09501050A (en) |
AU (1) | AU690916B2 (en) |
CA (1) | CA2168230A1 (en) |
WO (1) | WO1995004080A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100434023B1 (en) * | 1996-02-29 | 2005-05-09 | 주식회사 엘지생명과학 | Animal cell line expressing glycoprotein of varicella-zoster virus |
US5710248A (en) * | 1996-07-29 | 1998-01-20 | University Of Iowa Research Foundation | Peptide tag for immunodetection and immunopurification |
DK0966533T3 (en) | 1997-02-07 | 2010-01-04 | Us Gov Health & Human Serv | Activity-dependent neurotrophic factor III (ADNF III). |
US6197582B1 (en) * | 1998-03-18 | 2001-03-06 | The Trustees Of Columbia University In The City Of New York | Development of human monoclonal antibodies and uses thereof |
US7060802B1 (en) * | 2000-09-18 | 2006-06-13 | The Trustees Of Columbia University In The City Of New York | Tumor-associated marker |
CA2492883C (en) | 2002-08-01 | 2012-10-02 | James D. Marks | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
CN101146554B (en) | 2005-01-27 | 2012-10-10 | 加州大学评议会 | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
KR101154276B1 (en) * | 2006-11-17 | 2012-07-10 | 사이단호진한다이비세이부쯔뵤우겐큐우카이 | Nerve elongation promoter and elongation inhibitor |
JP2010517557A (en) * | 2007-02-06 | 2010-05-27 | リボバックス バイオテクノロジーズ ソシエテ アノニム | Antibodies specific for varicella-zoster virus |
US10066019B2 (en) | 2012-10-12 | 2018-09-04 | Agency For Science, Technology And Research | Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics |
US11147870B2 (en) * | 2018-04-25 | 2021-10-19 | Emory University | Specific binding agents to varicella-zoster virus and uses related thereto |
CN112386688B (en) * | 2021-01-20 | 2021-09-24 | 广东新征程生命科学有限公司 | A pharmaceutical composition containing immunocyte for treating virus |
CN114933649B (en) * | 2021-03-10 | 2023-04-21 | 北京智仁美博生物科技有限公司 | Antibodies against varicella-zoster virus and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2060509C (en) * | 1990-04-20 | 1996-07-23 | Yasuhiko Masuho | Human monoclonal antibody to glycoprotein gpiii of varicella zoster virus |
-
1994
- 1994-03-24 US US08/217,918 patent/US5506132A/en not_active Expired - Fee Related
- 1994-07-22 EP EP94922669A patent/EP0711310A4/en not_active Withdrawn
- 1994-07-22 JP JP7505890A patent/JPH09501050A/en not_active Ceased
- 1994-07-22 AU AU73700/94A patent/AU690916B2/en not_active Ceased
- 1994-07-22 CA CA002168230A patent/CA2168230A1/en not_active Abandoned
- 1994-07-22 WO PCT/US1994/008241 patent/WO1995004080A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
AU690916B2 (en) | 1998-05-07 |
CA2168230A1 (en) | 1995-02-09 |
AU7370094A (en) | 1995-02-28 |
EP0711310A1 (en) | 1996-05-15 |
WO1995004080A1 (en) | 1995-02-09 |
US5506132A (en) | 1996-04-09 |
JPH09501050A (en) | 1997-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601574D0 (en) | Humanized antibodies and uses thereof | |
ZA959336B (en) | Antibodies | |
IL122589A0 (en) | Vaccines against hepatitis c | |
ZA947828B (en) | Vaccines | |
GB9412166D0 (en) | Retargetting antibodies | |
EP0711310A4 (en) | Human antibodies against varicella-zoster virus | |
GB9325496D0 (en) | Vaccines | |
GB9304658D0 (en) | Flatus filters | |
ZA948685B (en) | Vaccines | |
ZA948729B (en) | Vaccines | |
GB9223676D0 (en) | Modified antibodies | |
GB9526433D0 (en) | Vaccine component | |
GB9213362D0 (en) | Hcv-3 virus | |
GB9508704D0 (en) | Virus | |
GB9320508D0 (en) | Antibodies | |
GB9309884D0 (en) | Antibodies | |
GB9420956D0 (en) | Virus | |
GB9421007D0 (en) | Virus | |
GB9222573D0 (en) | Antibodies | |
GB9207192D0 (en) | Antibodies | |
GB9312415D0 (en) | Altered antibodies | |
GB9526438D0 (en) | Vaccine component | |
GB9207360D0 (en) | Antigen preparation | |
GB9509425D0 (en) | "Virus" | |
GB9306398D0 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960228 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C12N 5/22 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19980622 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20000706 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20020226 |